Prognostic factors for cure following treatment of onychomycosis

Journal of the European Academy of Dermatology and Venereology : JEADV
B Sigurgeirsson

Abstract

To examine if host baseline factors and week 24 mycology results are associated with mycological and clinical cure in patients with onychomycosis treated with oral terbinafine. Open pilot study to determine prognostic factors in the treatment of onychomycosis. Outpatient dermatology clinic. A total of 199 patients from the Icelandic arm of a trial comparing continuous terbinafine with intermittent terbinafine in onychomycosis were recruited for additional observation. Mycological, clinical and complete cure of the target toenail 72 weeks after treatment was initiated. Patients with matrix involvement or slow nail growth were less likely to reach mycological, clinical and complete cure. Lateral involvement affected complete and mycological cure rates negatively. Patients with a dermatophytoma were less likely to reach mycological cure. Patients with a history of prior infection, men and older patients were less likely to reach clinical cure. Positive culture at 24 weeks affected mycological and clinical cure at 72 weeks negatively. Only patients treated with terbinafine were considered. Several host-related factors at baseline and positive culture at 24 weeks had negative effects on cure of onychomycosis 72 weeks after treatment...Continue Reading

References

Nov 1, 1995·The British Journal of Dermatology·H Heikkilä, S Stubb
Jan 13, 1998·Journal of the American Podiatric Medical Association·L A Levy
Apr 16, 1998·The British Journal of Dermatology·D T Roberts, E G Evans
Sep 3, 1999·Drugs·M Niewerth, H C Korting
Oct 11, 2002·Archives of Internal Medicine·Boni E ElewskiErcem Atillasoy
Nov 28, 2002·The British Journal of Dermatology·B SigurgeirssonE G V Evans
Feb 11, 2003·Acta Dermato-venereologica·Bárdur SigurgeirssonSnjólaug Sveinsdóttir
Jun 26, 2003·Clinical and Experimental Dermatology·S SommerE G V Evans
Sep 27, 2003·The British Journal of Dermatology·R K Scher, R Baran
Jan 17, 2004·Journal of the American Academy of Dermatology·Adam S GeyerRichard K Scher
Jul 13, 2004·Clinical and Experimental Dermatology·H-J YuJ-S Kim
Feb 10, 2006·The Journal of Dermatological Treatment·Bardur SigurgeirssonRajesh Bakshi

❮ Previous
Next ❯

Citations

Jul 27, 2011·Medical Mycology Journal·Takashi Harada
Aug 27, 2010·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Matilde IorizzoAntonella Tosti
Apr 1, 2016·Journal of the American Podiatric Medical Association·Tracey C VlahovicBryan C Markinson
Mar 26, 2016·Journal of the American Academy of Dermatology·Aditya K GuptaJessie L Carviel
Jul 24, 2014·Anais Brasileiros De Dermatologia·Christiane Venske de Almeida AzambujaMelissa Orzechowski Xavier
Mar 17, 2015·Journal of Cutaneous Medicine and Surgery·Aditya K Gupta, Maryse Paquet
Jan 29, 2019·Expert Opinion on Pharmacotherapy·Shari R Lipner
Sep 11, 2019·Journal of Cosmetic Dermatology·Naglaa A AbdallahMaha A Omar
Oct 12, 2019·Mycoses·Sandra WidatyHening Tirta Kusumawardhani
Jun 15, 2011·The British Journal of Dermatology·N VlassovaG S Lazarus
Apr 29, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Pietro NenoffGabriele Ginter-Hanselmayer
Nov 21, 2018·American Journal of Clinical Dermatology·Aditya K GuptaBianca Maria Piraccini
Jan 22, 2013·International Journal of Dermatology·Daniel Bennett, Adam I Rubin
Jul 1, 2018·Journal of the American Academy of Dermatology·Shari R Lipner, Richard K Scher
Jul 12, 2021·Journal de mycologie médicale·Luz Ángela Castro, María Inés Álvarez
Aug 17, 2021·The Australasian Journal of Dermatology·Sumanas BunyaratavejCharussri Leeyaphan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Indian Journal of Dermatology, Venereology and Leprology
S Grover
Journal of the European Academy of Dermatology and Venereology : JEADV
B Sigurgeirsson, O Steingrímsson
Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA
Ju Wen, Zhong-fang Lin
The Annals of Pharmacotherapy
E F Trépanier, G W Amsden
© 2022 Meta ULC. All rights reserved